• iphepha - 1

Ukusetyenziswa kwezonyango kwikiti yoVavanyo lweTyphoid, inyathelo elinye lovavanyo olukhawulezayo lwekhasethi

Inkcazelo emfutshane:


Iinkcukacha zeMveliso

Iithegi zeMveliso

Uvakalelo lweKlinikhi, Ukuchaneka nokuchaneka

Uvavanyo lwe-Influenza A+B Antigen Rapid Test luvavanyiwe xa luthelekiswa ne-RT-PCR.I-539 ye-nasopharyngeal swabs kunye ne-oropharyngeal swabs zavandlakanywa kunye novavanyo olukhawulezayo lwe-Influenza A + B.

Izinto

Ukugxila

Izinto

Ukugxila

Ukutshiza ngeempumlo

15% v/v

IHemoglobin

10% v/v

Mucin

0.5 % w/v

Mupirocin

10 mg/mL

Amathontsi ngeempumlo

15% v/v

Ukuhlamba imilomo

/

I-Chloraseptic

1.5 mg/mL

Levofloxacin

40 ug/mL

I-Oseltamivir

2ug/mL

I-Ribavirin

0.2ug/mL

I-Fluticasone propionate

5% v/v

Ceftriaxone

800 ug/mL

Tobramycin

4ug/mL

I-Saline yeeNcinci zokutshiza

10% v/v

NgoMkhuhlane A

Indlela

I-RT-PCR

Zizonke iziphumo

Uvavanyo loMkhuhlane A+B oluKhawulezayo

Iziphumo

Okuhle

Ibi

Okuhle

116

1

117

Ibi

5

417

422

Zizonke iziphumo

121

418

539

Uvakalelo lweklinikhi: 95.87% (95% CI: 90.69% ~ 98.22%)
Ubungcali beklinikhi: 99.76% (95% CI: 98.66% ~ 99.96%)
Ireyithi yeNxulumano iyonke: 98.89% (95% CI: 97.59% ~ 99.49%).

NgoMkhuhlane B:

Indlela

I-RT-PCR

Zizonke iziphumo

Uvavanyo loMkhuhlane A+B oluKhawulezayo

Iziphumo

Okuhle

Ibi

Okuhle

97

1

98

Ibi

6

435

441

Zizonke iziphumo

103

436

539

Uvakalelo lweklinikhi: 94.17% (95% CI: 87.87% ~ 97.30%)
Ubungcali beklinikhi: 99.77% (95% CI: 98.71% ~ 99.96%)
Ireyithi yeNxulumaniso iyonke: 98.70% (95% CI: 97.34% ~ 99.37%).

Uvakalelo lokuHlalutya/LOD

 img-1 Hangzhou Aichek Medical Technology CO., Ltd.

Jinxing Cun, Yuhang Community, Yuhang

ISithili (IsiXeko seSayensi seNzululwazi yekamva), iHangzhou,

Zhejiang, PR China

 img-2 SUNGO Europe BV

I-Olympisch Stadion 24, 1076DE Amsterdam, Netherlands

Umda wokubhaqwa (LOD) ichongiwe ngokuvavanywa koxinzelelo olwahlukileyo lwentsholongwane yomkhuhlane A kunye nentsholongwane yomkhuhlane B kuMkhuhlane A+B we-Antigen Rapid Test.Ugxininiso oluchongwe njengamanqanaba eLOD avavanyiweyo zidweliswe ngezantsi.
Umkhuhlane A (H3N2): 5×103 TCID50/mL
Umkhuhlane A (H1N1): 2.5×103 TCID50/mL
Umkhuhlane A (H1N1 pdm09): 2.5×103 TCID50/mL
Umkhuhlane B (Yamagata): 3.5×103 TCID50/mL
I-Influenza B (i-Victoria): 1.0 × 103 TCID50 / mL

Ukuchaneka koHlahlo (Ukuphinda kusebenze kwakhona ngokunqamlezayo)

Ukumisela uhlalutyo oluthile lwe-Influenza A + B ye-Antigen Rapid Test, ii-microorganisms ezininzi ze-commensal okanye ze-pathogenic ezinokubakho kwindlela yokuphefumula ephezulu zavavanywa.
Iisampulu ezintle nezimbi zaye zajongwa ngezi ntsholongwane zavavanywa kuxinaniso lwe-106 TCID50/mL, kubandakanywa i-SARS-CoV-2, i-Human coronavirus HKU1, OC43, NL63, 229E, MERS, Rhinovirus, Adenovirus, Enterovirus, Metapneumotoryeumovirus, iParainflunza, iParainflunza syncytial virus, Mycoplasma pneumonia, Chlamydia pneumonia, Streptococcus pneumonia, Staphylococcus aureus, Mycobacterium tuberculosis, Haemophilus influenzae, Streptococcus pyogenes.Akukho kuphinda kusebenze kwakhona kubonwe ngoMkhuhlane A+B Antigen Rapid Test.

UKUSETYENZISWA OKUHLOSIWEYO

Umkhuhlane A+B Antigen Rapid Test is a lateral flow immunoassay eyenzelwe ukufunyaniswa komgangatho womkhuhlane A kunye neantigens zomkhuhlane B kwiswab ye-nasopharyngeal kunye ne-oropharyngeal swab.

Inzuzo yeNkampani

1. UMvelisi oyiNgcali, ishishini “eliphambili” elikwinqanaba lesizwe
2.Hambisa iimpahla njengesicelo somyalelo
3.ISO13485, CE, Lungisa amaxwebhu ahlukeneyo okuthumela
4.Phendula imibuzo yabathengi kwiiyure ezingama-24


  • Ngaphambili:
  • Okulandelayo:

  • Bhala umyalezo wakho apha kwaye uwuthumele kuthi